Prognostic Relevance of Clinical and Tumor Mutational Profile in High-Grade Serous Ovarian Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Genetic mutations impact overall survival and treatment response in high-grade serous ovarian cancer cases, suggesting targeted therapies.

Mutational analysis shows a significant correlation between the number of mutations and poorer overall survival.
Notably, mutations in ERBB4 and other genes are strongly linked to adverse outcomes in ovarian cancer patients.
The study utilizes next-generation sequencing to examine tumor samples from patients undergoing different treatment approaches.
Findings indicate distinct mutational profiles between patients receiving primary debulking surgery and those on neoadjuvant chemotherapy.

Martín-Vallejo et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Genetic mutations impact overall survival and treatment response in high-grade serous ovarian cancer cases, suggesting targeted therapies.